Authors:
Dawkins, HJS
Sellner, LN
Turbett, GR
Thompson, CA
Redmond, SL
McNeal, JE
Cohen, RJ
Citation: Hjs. Dawkins et al., Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecularmarkers of cancer progression, PROSTATE, 44(4), 2000, pp. 265-270
Authors:
Williams, JF
Muenchen, HJ
Kamradt, JM
Korenchuk, S
Pienta, KJ
Citation: Jf. Williams et al., Treatment of androgen-independent prostate cancer using antimicrotubule agents docetaxel and estramustine in combination: An experimental study, PROSTATE, 44(4), 2000, pp. 275-278
Citation: K. Gunawardena et al., Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis, PROSTATE, 44(4), 2000, pp. 287-295
Authors:
Scott, KM
Fanta, P
Calaluce, R
Dalkin, B
Weinstein, RS
Nagle, RB
Citation: Km. Scott et al., Diagnostic frozen prostate sextant biopsies: An approach for preserving protein and RNA for additional studies, PROSTATE, 44(4), 2000, pp. 296-302
Citation: Ay. Liu et al., Changes in cell surface molecules associated with in vitro culture of prostatic stromal cells, PROSTATE, 44(4), 2000, pp. 303-312
Authors:
Schipper, RG
Deli, G
Deloyer, P
Lange, WPHJ
Schalken, JA
Verhofstad, AAJ
Citation: Rg. Schipper et al., Antitumor activity of the polyamine analog N-I,N-II-diethylnorspermine against human prostate carcinoma cells, PROSTATE, 44(4), 2000, pp. 313-321
Citation: H. Fukuda et al., Anatomic distribution of intraprostatic lymphatics: Implications for the lymphatic spread of prostate cancer - A preliminary study, PROSTATE, 44(4), 2000, pp. 322-327
Citation: N. Takahashi et al., Low-dose staurosporine suppresses proliferation and induces neurites in human prostatic cancer TSU-Pr1 cells, PROSTATE, 44(4), 2000, pp. 328-333
Citation: Rt. O'Donnell et al., Efficacy and toxicity of radioimmunotherapy with Y-90-DOTA-Peptide-ChL6 for PC3-tumored mice, PROSTATE, 44(3), 2000, pp. 187-192
Citation: Rj. Cohen et al., Identification of the glycosaminoglycan keratan sulfate in the prostatic secretory cell, PROSTATE, 44(3), 2000, pp. 204-209
Authors:
Okegawa, T
Noda, H
Kato, M
Miyata, A
Nutahara, K
Higashihara, E
Citation: T. Okegawa et al., Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer, PROSTATE, 44(3), 2000, pp. 210-218
Authors:
Span, PN
van Bokhoven, A
Smals, AGH
Sweep, CGJ
Schalken, JA
Citation: Pn. Span et al., Partial sequencing and tissue distribution of the canine isoforms of steroid 5 alpha-reductase type I and type II, PROSTATE, 44(3), 2000, pp. 233-239
Authors:
Zermann, DH
Ishigooka, M
Doggweiler, R
Schubert, J
Schmidt, RA
Citation: Dh. Zermann et al., Central nervous system neurons labeled following the injection of pseudorabies virus into the rat prostate gland, PROSTATE, 44(3), 2000, pp. 240-247
Authors:
Kumar, A
Mikolajczyk, SD
Hill, TM
Millar, LS
Saedi, MS
Citation: A. Kumar et al., Different proportions of various prostate-specific antigen (PSA) and humankallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells, PROSTATE, 44(3), 2000, pp. 248-254
Authors:
Thalmann, GN
Sikes, RA
Wu, TT
Degeorges, A
Chang, SM
Ozen, M
Pathak, S
Chung, LWK
Citation: Gn. Thalmann et al., LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis, PROSTATE, 44(2), 2000, pp. 91-103
Authors:
Goulas, A
Hatzichristou, DG
Karakiulakis, G
Mirtsou-Fidani, V
Kalinderis, A
Papakonstantinou, E
Citation: A. Goulas et al., Benign hyperplasia of the human prostate is associated with tissue enrichment in chondroitin sulphate of wide size distribution, PROSTATE, 44(2), 2000, pp. 104-110